Stock NHI NATIONAL HEALTH INVESTORS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus National Health Investors, Inc.

Equities

NHI

US63633D1046

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-24 pm EDT 		5-day change 1st Jan Change
62.85 USD +0.18% Intraday chart for National Health Investors, Inc. +5.54% +12.53%
Apr. 18 Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting CI
Mar. 18 Wedbush Raises National Health Investors' PT to $66 From $64 After Investor Meetings With Management, Maintains Outperform Rating MT

Evolution of the average Target Price on National Health Investors, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a115dbc4c0351ffb70908a5cf887470e.H9V6JwAK3JoBMgpC6MBriYtutj60IAvKXWJ-IT5WsTs.fJA1UjZBiLdCZV04qZBS58QIhG_4U2CaElJTQlQH_kJcvjxWMzno22dwfQ~609dfbdd30023f2af3d2a8a96523eda7

Analyst Recommendations on National Health Investors, Inc.

Wedbush Raises National Health Investors' PT to $66 From $64 After Investor Meetings With Management, Maintains Outperform Rating MT
BMO Capital Upgrades National Health Investors to Outperform From Market Perform MT
Wells Fargo Upgrades National Health Investors to Overweight From Equalweight, Price Target is $63 MT
Wells Fargo Upgrades National Health Investors to Overweight From Equalweight, Adjusts Price Target to $63 From $55 MT
Wedbush Upgrades National Health Investors to Outperform From Neutral, Says More Optimistic on Skilled Nursing Facilities/Senior Housing; Raises PT to $64 From $57 MT
Deutsche Bank Initiates Coverage on National Health Investors With Buy Rating, $69 Price Target MT
Wells Fargo Adjusts National Health Investors' Price Target to $55 From $54, Maintains Equal-Weight Rating MT
Wedbush Starts National Health Investors at Neutral With $54 Price Target MT
Jefferies Initiates National Health Investors With Hold Rating, Price Target is $52 MT
Truist Securities Adjusts National Health Investors Price Target to $57 From $56, Maintains Hold Rating MT
Wells Fargo Adjusts Price Target on National Health Investors to $54 From $52, Maintains Equalweight Rating MT
Fitch Affirms National Health Investors at 'BBB-'; Outlook Stable AQ
Credit Suisse Lowers National Health Investors' Price Target to $50 From $55, Says Still Cautious About Tenant Credit Risk; Keeps Neutral Rating MT
Credit Suisse Upgrades National Health Investors to Neutral From Underperform, Raises PT to $58 From $47; Revises Estimates to Reflect Q3 Results, Asset Sales MT
Moody's Affirms National Health Investor's Baa3 Rating; Outlook Revised to Stable MT
Truist Securities Adjusts Price Target on National Health Investors to $61 From $64, Reiterates Hold Rating MT
Berenberg Bank Raises Price Target on National Health Investors to $66 From $58, Maintains Hold Rating MT
Stifel Nicolaus Adjusts National Health Investors Price Target to $66 From $56, Maintains Hold Rating MT
Credit Suisse Initiates 24 REIT Stocks, Names 5 Top Picks, Says Inflation Protection to Partially Offset Impact of Rising Rates MT
BMO Capital Downgrades National Health Investors to Market Perform From Outperform; Price Target is $62 MT
Berenberg Bank Adjusts Price Target on National Health Investors to $58 From $62, Maintains Hold Rating MT
BMO Capital Adjusts Price Target on National Health Investors to $61 From $63, Keeps Outperform Rating MT
Berenberg Bank Adjusts National Health Investors' Price Target to $62 From $57, Maintains Hold Rating MT
Credit Suisse Initiates Coverage of 12 Healthcare REITs; Says Prospect of Rising Rates, COVID-19 Omicron Variant Pose Sector-Wide Uncertainty MT
BMO Capital Upgrades National Health Investors to Outperform From Market Perform; Price Target is $68 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
62.85 USD
Average target price
62.83 USD
Spread / Average Target
-0.03%
High Price Target
69 USD
Spread / Highest target
+9.79%
Low Price Target
54 USD
Spread / Lowest Target
-14.08%

Consensus detail

Consensus revision (last 18 months)

Analysts covering National Health Investors, Inc.

Wedbush
BMO Capital
Wells Fargo Securities
Deutsche Bank Securities
Jefferies & Co.
Truist Securities
Credit Suisse
Berenberg Bank
Stifel Nicolaus
Capital One Securities
Mizuho Securities

Ratings for National Health Investors, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NHI Stock
  4. Consensus National Health Investors, Inc.